Key result
Chronic losartan treatment markedly reduced 24-h mean arterial pressure in insulin-treated rats (-38 ± 1 mmHg) compared with losartan-treated controls (-18 ± 1 mmHg, P≤0.05).
Why the study?
Does chronic insulin infusion increase blood pressure or sympathetic activity in female Sprague-Dawley rats?
Does chronic insulin infusion increase blood pressure or sympathetic activity in female Sprague-Dawley rats?
Absolute Event Rate: -38% vs -18%
p-value: p=≤0.05
Chronic insulin infusion in rats does not cause hypertension or increase sympathetic activity per se, but reveals a significant interaction with the renin-angiotensin aldosterone system in blood pressure control.
Indicates RAAS-insulin interaction in rat BP control; leaves open translation to human hypertension.
The effect of insulin on blood pressure (BP) is debated, and an involvement of an activated renin-angiotensin aldosterone system (RAAS) has been suggested. We studied the effect of chronic insulin infusion on telemetry BP and assessed sympathetic activity and dependence of the RAAS. Female Sprague-Dawley rats received insulin (2 units/day, INS group, n = 12) or insulin combined with losartan (30 mg·kg−1·day−1, INS+LOS group, n = 10), the angiotensin II receptor antagonist, for 6 wk. Losartan-treated (LOS group, n = 10) and untreated rats served as controls ( n = 11). We used telemetry to measure BP and heart rate (HR), and acute ganglion blockade and air-jet stress to investigate possible control of BP by the sympathetic nervous system. In addition, we used myograph technique to study vascular function ex vivo. The INS and INS+LOS groups developed euglycemic hyperinsulinemia. Insulin did not affect BP but increased HR (27 beats/min on average). Ganglion blockade reduced mean arterial pressure (MAP) similarly in all groups. Air-jet stress did not increase sympathetic reactivity but rather revealed possible blunting of the stress response in hyperinsulinemia. Chronic losartan markedly reduced 24-h-MAP in the INS+LOS group (−38 ± 1 mmHg P < 0.001) compared with the LOS group (−18 ± 1 mmHg, P ≤ 0.05). While insulin did not affect vascular function per se, losartan improved endothelial function in the aorta of insulin-treated rats. Our results raise doubt regarding the role of hyperinsulinemia in hypertension. Moreover, we found no evidence that insulin affects sympathetic nervous system activity. However, chronic losartan treatment revealed an important interaction between insulin and RAAS in BP control.
No takes yet. Share an insight, caveat, or question.
Johansson et al. (2008) studied Hyperinsulinemia and blood pressure regulation (n=43). Insulin combined with losartan vs. Losartan alone and untreated controls was evaluated on 24-h mean arterial pressure (MAP) (p=≤0.05). Chronic losartan treatment markedly reduced 24-h mean arterial pressure in insulin-treated rats (-38 ± 1 mmHg) compared with losartan-treated controls (-18 ± 1 mmHg, P≤0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: